logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CKI Holdings (01038) appoints Gao Baohua as an independent non-executive director of the company.

date
15:29 31/12/2025
avatar
GMT Eight
The Yangtze River Infrastructure Group (01038) announced the appointment of Ms. Gao Baohua as an independent non-executive director and member of the audit committee, effective from January 1, 2026.
CKI Holdings (01038) has announced the appointment of Ms. Gao Baohua as an independent non-executive director and a member of the audit committee, effective from January 1, 2026.
Related Articles
HK Stock
HBM Holdings-B (02142) spent 1.2194 million Hong Kong dollars to repurchase 100,000 shares on December 31st.
HK Stock
GET NICE (00064): Gao Yifei appointed as Company Secretary and Authorized Representative.
HK Stock
CF PHARMTECH purchased 43,000 shares, spending 1.4565 million Hong Kong dollars on December 31st.
HBM Holdings-B (02142) spent 1.2194 million Hong Kong dollars to repurchase 100,000 shares on December 31st.
HK Stock
GET NICE (00064): Gao Yifei appointed as Company Secretary and Authorized Representative.
HK Stock
CF PHARMTECH purchased 43,000 shares, spending 1.4565 million Hong Kong dollars on December 31st.
HK Stock
RECOMMEND
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
icon
29/12/2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
icon
29/12/2025
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
icon
29/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.